Drug interactions
Belatacept + Liposomal doxorubicin
Severity: Major
Belatacept and Liposomal doxorubicin: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Both drugs suppress immune function, and combined use increases susceptibility to serious infections and malignancy, including post-transplant lymphoproliferative disorder with belatacept. Liposomal doxorubicin also causes myelosuppression.
What this interaction means in plain words
Belatacept and Liposomal doxorubicin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Belatacept belongs to Miscellaneous; Liposomal doxorubicin belongs to Oncology.
Why it happens
Additive immunosuppression and myelosuppression.
What to do
Monitor blood counts and for signs of infection, and review the need for belatacept during chemotherapy with the transplant team. Consider antimicrobial prophylaxis as appropriate.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Belatacept and Liposomal doxorubicin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Liposomal doxorubicin
- Dengue vaccine + Liposomal doxorubicin Contraindicated
- Cyclosporine + Liposomal doxorubicin Major
- Dronedarone + Liposomal doxorubicin Major
- Elvitegravir / cobicistat / emtricitabine / tenofovir df + Liposomal doxorubicin Major
- Fingolimod + Liposomal doxorubicin Major
- Ganciclovir + Liposomal doxorubicin Major
Other interactions of Belatacept
Frequently asked questions
Can I take Belatacept with Liposomal doxorubicin?
MediHelp rates the interaction as major. Belatacept and Liposomal doxorubicin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs suppress immune function, and combined use increases susceptibility to serious infections and malignancy, including post-transplant lymphoproliferative disorder with belatacept. Liposomal doxorubicin also causes myelosuppression.
How serious is the interaction between Belatacept and Liposomal doxorubicin?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and for signs of infection, and review the need for belatacept during chemotherapy with the transplant team. Consider antimicrobial prophylaxis as appropriate.
What other medicines interact with Liposomal doxorubicin?
MediHelp also lists interactions of Liposomal doxorubicin with, for example, Dengue vaccine, Cyclosporine, Dronedarone. The full list is on the Liposomal doxorubicin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
